Satyaraddi Anil, Cherian Kripa Elizabeth, Kapoor Nitin, Kunjummen Aleyamma Thaiparambil, Kamath Mohan S, Thomas Nihal, Paul Thomas V
Department of Endocrinology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Department of Reproductive Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
J Hum Reprod Sci. 2019 Apr-Jun;12(2):78-84. doi: 10.4103/jhrs.JHRS_2_19.
The objective was to compare body composition, metabolic characteristics, and insulin resistance between obese (body mass index [BMI] ≥25 kg/m) polycystic ovary syndrome (PCOS) and nonobese PCOS (BMI <25 kg/m) women and their age- and BMI-matched controls.
A total of 81 PCOS women (Rotterdam criteria) (obese - 42; nonobese - 39) and 86 controls (obese - 42; nonobese -44) were recruited in this cross-sectional study. All women underwent a detailed assessment of clinical, anthropometric, and metabolic parameters, insulin resistance indices, and body composition measurements with visceral adipose tissue assessment (VAT) (dual-energy X-ray absorptiometry scan).
Of PCOS women, 27% (80% - obese PCOS; 20% - nonobese PCOS) were diagnosed with metabolic syndrome (International Diabetes Federation criteria), 35% of PCOS women (46% - obese PCOS; 54% - nonobese PCOS) had impaired glucose tolerance, and 7% of PCOS women (2/3 - obese PCOS; 1/3 - nonobese PCOS) had diabetes mellitus. Insulin resistance was seen in about 80% in obese PCOS women and 20% in nonobese PCOS women based on various insulin resistance indices such as fasting insulin (≥12.2 μU/ml), Homeostasis Model Assessment-Insulin Resistance (≥2.5), and Quantitative Insulin Sensitivity Check Index (<0.33). Total body fat, estimated (Est.) VAT, and corrected Est. VAT (corrected for body weight) were significantly increased ( = 0.0001) in both obese and nonobese PCOS women when compared to those of their age- and BMI-matched controls. However, corrected Est. VAT (corrected for body weight) was not significantly different between obese and nonobese PCOS women.
Both obese and nonobese PCOS women when compared with their age- and BMI-matched controls were metabolically worse and had more visceral adiposity. Nonobese PCOS poses similar risk as that of obese PCOS in having similar amount of VAT (corrected for body weight).
比较肥胖(体重指数[BMI]≥25kg/m²)多囊卵巢综合征(PCOS)女性与非肥胖PCOS(BMI<25kg/m²)女性及其年龄和BMI匹配的对照者之间的身体成分、代谢特征和胰岛素抵抗情况。
在这项横断面研究中,共招募了81名PCOS女性(符合鹿特丹标准)(肥胖者42名;非肥胖者39名)和86名对照者(肥胖者42名;非肥胖者44名)。所有女性均接受了临床、人体测量学和代谢参数、胰岛素抵抗指数以及通过内脏脂肪组织评估(VAT)(双能X线吸收法扫描)进行的身体成分测量的详细评估。
在PCOS女性中,27%(80%为肥胖PCOS;20%为非肥胖PCOS)被诊断为代谢综合征(国际糖尿病联盟标准),35%的PCOS女性(46%为肥胖PCOS;54%为非肥胖PCOS)糖耐量受损,7%的PCOS女性(2/3为肥胖PCOS;1/3为非肥胖PCOS)患有糖尿病。根据空腹胰岛素(≥12.2μU/ml)、稳态模型评估-胰岛素抵抗(≥2.5)和定量胰岛素敏感性检查指数(<0.33)等各种胰岛素抵抗指数,约80%的肥胖PCOS女性和20%的非肥胖PCOS女性存在胰岛素抵抗。与年龄和BMI匹配的对照者相比,肥胖和非肥胖PCOS女性的全身脂肪、估计的VAT和校正后的估计VAT(校正体重后)均显著增加(P = 0.0001)。然而,肥胖和非肥胖PCOS女性校正后的估计VAT(校正体重后)无显著差异。
与年龄和BMI匹配的对照者相比,肥胖和非肥胖PCOS女性的代谢情况更差,内脏脂肪更多。非肥胖PCOS在具有相似量的VAT(校正体重后)方面与肥胖PCOS具有相似的风险。